$DHC
Diversified Healthcare Trust Stock $dhc

$dhc Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000107541524000015 Filed on May 06, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$371.4M	$370.8M
YoY Change	7.27%	7.15%
Cost Of Revenue	$304.1M	$307.6M
YoY Change	6.23%	7.52%
Gross Profit	$67.33M	$63.17M
YoY Change	12.23%	5.37%
Gross Profit Margin	18.13%	17.04%
Selling, General & Admin	$6.262M	$7.568M
YoY Change	-14.03%	28.86%
% of Gross Profit	9.3%	11.98%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$68.36M	$70.13M
YoY Change	-0.05%	8.23%
% of Gross Profit	101.53%	111.02%
Operating Expenses	$74.62M	$77.70M
YoY Change	-1.4%	9.94%
Operating Profit	-$7.292M	-$14.53M
YoY Change	-53.52%	35.49%
Interest Expense	$58.70M	$57.58M
YoY Change	-238.94%	20.5%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$85.38M	-$87.97M
YoY Change	13.42%	69.04%
Income Tax	$170.0K	$187.0K
% Of Pretax Income
Net Earnings	-$97.86M	-$86.26M
YoY Change	34.85%	63.81%
Net Earnings / Revenue	-26.35%	-23.26%
Basic Earnings Per Share	-$0.41	-$0.36
Diluted Earnings Per Share	-$0.41	-$0.36
COMMON SHARES
Basic Shares Outstanding	240.4M shares	240.4M shares
Diluted Shares Outstanding	239.3M shares	239.2M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$265.6M	$207.1M
YoY Change	-21.53%	-45.51%
Cash & Equivalents	$265.6M	$207.1M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$265.6M	$207.1M
YoY Change	-21.53%	-45.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.677B	$4.731B
YoY Change	-3.15%	-2.85%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$24.91M	$15.74M
YoY Change	-83.94%	-89.74%
Other Assets	$48.49M	$39.15M
YoY Change	19.22%	1433.97%
Total Long-Term Assets	$5.068B	$5.141B
YoY Change	-3.41%	-2.76%
TOTAL ASSETS
Total Short-Term Assets	$265.6M	$207.1M
Total Long-Term Assets	$5.068B	$5.141B
Total Assets	$5.333B	$5.348B
YoY Change	-4.51%	-5.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$45.31M	$46.69M
YoY Change	-15.38%	-19.6%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$45.31M	$46.69M
YoY Change	-15.38%	-19.6%
LONG-TERM LIABILITIES
Long-Term Debt	$2.920B	$2.838B
YoY Change	4.86%	1.41%
Other Long-Term Liabilities	$218.9M	$214.8M
YoY Change	-8.04%	-5.11%
Total Long-Term Liabilities	$3.139B	$3.053B
YoY Change	3.85%	0.92%
TOTAL LIABILITIES
Total Short-Term Liabilities	$45.31M	$46.69M
Total Long-Term Liabilities	$3.139B	$3.053B
Total Liabilities	$3.184B	$3.099B
YoY Change	3.51%	0.53%
SHAREHOLDERS EQUITY
Retained Earnings	$1.594B	$1.692B
YoY Change	-18.11%	-16.2%
Common Stock	$4.622B	$4.621B
YoY Change	0.04%	0.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.149B	$2.249B
YoY Change
Total Liabilities & Shareholders Equity	$5.333B	$5.348B
YoY Change	-4.51%	-5.62%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$97.86M	-$86.26M
YoY Change	34.85%	63.81%
Depreciation, Depletion And Amortization	$68.36M	$70.13M
YoY Change	-0.05%	8.23%
Cash From Operating Activities	$44.29M	$28.60M
YoY Change	72.47%	373.39%
INVESTING ACTIVITIES
Capital Expenditures	$41.00M	$46.72M
YoY Change	-13.95%	-22.51%
Acquisitions
YoY Change
Other Investing Activities	$4.145M	-$12.12M
YoY Change	-70.41%	-441.49%
Cash From Investing Activities	-$36.85M	-$58.84M
YoY Change	9.56%	3.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	54.48M	-$8.561M
YoY Change	-409.01%	-96.64%
NET CHANGE
Cash From Operating Activities	44.29M	$28.60M
Cash From Investing Activities	-36.85M	-$58.84M
Cash From Financing Activities	54.48M	-$8.561M
Net Change In Cash	61.92M	-$38.80M
YoY Change	-342.02%	-87.31%
FREE CASH FLOW
Cash From Operating Activities	$44.29M	$28.60M
Capital Expenditures	$41.00M	$46.72M
Free Cash Flow	$3.295M	-$18.12M
YoY Change	-115.0%	-66.6%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	370776000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	346030000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssets
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssets
CY2024Q1	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilities
CY2023Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilities
CY2024Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	307604000	usd
CY2023Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	286080000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	70133000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	64800000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7568000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5873000	usd
CY2024Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	86000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	93000	usd
CY2024Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	12142000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5925000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	397533000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	362771000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	-5874000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	1233000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	8126000	usd
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	2237000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	4195000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	24863000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2074000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	57576000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	47780000	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1075000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-87970000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-52042000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	187000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-31000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-86259000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-52658000	usd
CY2024Q1	us-gaap	Oci Equity Method Investment After Tax OciEquityMethodInvestmentAfterTax	-4000	usd
CY2023Q1	us-gaap	Oci Equity Method Investment After Tax OciEquityMethodInvestmentAfterTax	0	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-86263000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-52658000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	239193000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	239193000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	238589000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	238589000	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2336891000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-86259000	usd
CY2024Q1	us-gaap	Oci Equity Method Investment After Tax OciEquityMethodInvestmentAfterTax	-4000	usd
CY2024Q1	us-gaap	Dividends Common Stock DividendsCommonStock	2404000	usd
CY2024Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	558000	usd
CY2024Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	79000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	2248703000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2638611000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-52658000	usd
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	2397000	usd
CY2023Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	270000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	6000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	1000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2583819000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-86259000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-52658000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	70133000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	64800000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	24863000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2074000	usd
CY2024Q1	us-gaap	Straight Line Rent StraightLineRent	291000	usd
CY2023Q1	us-gaap	Straight Line Rent StraightLineRent	2448000	usd
CY2024Q1	dhc	Amortization Of Acquired Real Estate Leases And Other Intangible Assets AmortizationOfAcquiredRealEstateLeasesAndOtherIntangibleAssets	28000	usd
CY2023Q1	dhc	Amortization Of Acquired Real Estate Leases And Other Intangible Assets AmortizationOfAcquiredRealEstateLeasesAndOtherIntangibleAssets	-311000	usd
CY2024Q1	dhc	Gain Loss On Early Extinguishment Of Debt GainLossOnEarlyExtinguishmentOfDebt	0	usd
CY2023Q1	dhc	Gain Loss On Early Extinguishment Of Debt GainLossOnEarlyExtinguishmentOfDebt	-1075000	usd
CY2024Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	12142000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5925000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	-5874000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	1233000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	0	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	8126000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	385000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	674000	usd
CY2024Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	1231000	usd
CY2023Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	1411000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1898000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-647000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Leasing Fees IncreaseDecreaseInDeferredLeasingFees	669000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Leasing Fees IncreaseDecreaseInDeferredLeasingFees	1954000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-10102000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-15499000	usd
CY2024Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	904000	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	2540000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-7173000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-20525000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	28602000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6042000	usd
CY2024Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	46723000	usd
CY2023Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	60292000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	3343000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	3548000	usd
CY2024Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	15459000	usd
CY2023Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-58839000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-56744000	usd
CY2024Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	250000000	usd
CY2024Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	822000	usd
CY2023Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	538000	usd
CY2024Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	5257000	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1990000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	78000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6000	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2404000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2397000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8561000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-254931000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-38798000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-305633000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	246961000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	688302000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	208163000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	382669000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	31809000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	43166000	usd
CY2024Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2024Q1	dhc	Receivable From Tender Offer ReceivableFromTenderOffer	0	usd
CY2023Q1	dhc	Receivable From Tender Offer ReceivableFromTenderOffer	14006000	usd
CY2024Q1	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	17369000	usd
CY2023Q1	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	20195000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	207123000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	380117000	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	1040000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	2552000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	208163000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	382669000	usd
CY2024Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	371	property
CY2024Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	36	state
CY2024Q1	dhc	Number Of States NumberOfStates	5	state
CY2024Q1	dhc	Number Of Properties Acquired NumberOfPropertiesAcquired	0	property
CY2024Q1	us-gaap	Straight Line Rent StraightLineRent	291000	usd
CY2023Q1	us-gaap	Straight Line Rent StraightLineRent	2448000	usd
CY2024Q1	dhc	Straight Line Rent Excluding Properties Heldfor Sale StraightLineRentExcludingPropertiesHeldforSale	74704000	usd
CY2023Q4	dhc	Straight Line Rent Excluding Properties Heldfor Sale StraightLineRentExcludingPropertiesHeldforSale	75306000	usd
CY2024Q1	us-gaap	Variable Lease Payment VariableLeasePayment	11350000	usd
CY2023Q1	us-gaap	Variable Lease Payment VariableLeasePayment	11986000	usd
CY2024Q1	dhc	Reimbursement Revenue Lease ReimbursementRevenueLease	11284000	usd
CY2023Q1	dhc	Reimbursement Revenue Lease ReimbursementRevenueLease	11924000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	22555000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	22937000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	23366000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	23748000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.01
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2404000	usd
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	370776000	usd
CY2024Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	307604000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	70133000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7568000	usd
CY2024Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	86000	usd
CY2024Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	12142000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	397533000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	-5874000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	usd
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	2237000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	57576000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-87970000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	187000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1898000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-86259000	usd
CY2024Q1	us-gaap	Assets Assets	5348037000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	346030000	usd
CY2023Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	286080000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	64800000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5873000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	93000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5925000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	362771000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	1233000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	8126000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	4195000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	47780000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1075000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-52042000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-31000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-647000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-52658000	usd
CY2023Q4	us-gaap	Assets Assets	5446136000	usd
CY2024Q1	dei	Entity Number Of Employees EntityNumberOfEmployees	0	employee
CY2024Q1	dhc	Property Management And Construction Supervision Fees PropertyManagementAndConstructionSupervisionFees	1904000	usd
CY2023Q1	dhc	Property Management And Construction Supervision Fees PropertyManagementAndConstructionSupervisionFees	1992000	usd
CY2024Q1	dhc	Property Management And Construction Supervision Fees Paid PropertyManagementAndConstructionSupervisionFeesPaid	3728000	usd
CY2023Q1	dhc	Property Management And Construction Supervision Fees Paid PropertyManagementAndConstructionSupervisionFeesPaid	3533000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	187000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-31000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
dhc-20240331_cal.xml	Edgar Link	unprocessable
0001075415-24-000015-index-headers.html	Edgar Link	pending
0001075415-24-000015-index.html	Edgar Link	pending
0001075415-24-000015.txt	Edgar Link	pending
0001075415-24-000015-xbrl.zip	Edgar Link	pending
dhc-20240331.htm	Edgar Link	pending
dhc-20240331.xsd	Edgar Link	pending
dhc_033124xexhibitx101.htm	Edgar Link	pending
dhc_033124xexhibitx102.htm	Edgar Link	pending
dhc_033124xexhibitx103.htm	Edgar Link	pending
dhc_033124xexhibitx311.htm	Edgar Link	pending
dhc_033124xexhibitx312.htm	Edgar Link	pending
dhc_033124xexhibitx321.htm	Edgar Link	pending
dhc_033124xexhibitx411.htm	Edgar Link	pending
dhc_033124xexhibitx416.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
dhc-20240331_def.xml	Edgar Link	unprocessable
dhc-20240331_lab.xml	Edgar Link	unprocessable
dhc-20240331_pre.xml	Edgar Link	unprocessable
dhc-20240331_htm.xml	Edgar Link	completed
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DHC
Diversified Healthcare Trust Stock $dhc

2024 Q2 Form 10-Q Financial Statement

#000107541524000015 Filed on May 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DHC Diversified Healthcare Trust Stock $dhc

2024 Q2 Form 10-Q Financial Statement

#000107541524000015 Filed on May 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DHC
Diversified Healthcare Trust Stock $dhc